Corona vaccine, tratal in Bangladesh by breathing through the nose

shear

nose at Just take a breath and take your vaccines, and you will get the vaccine, not just that, this vaccine is 100% effective against all the variants of the coronavirus.

Registration on websites, going to hospital, staying in huge queues, storing vaccines in air-conditioned places, vaccination through health workers—these can be the past. You will get vaccinated as you like, yourself.

This is what has been said about a powder vaccine. Bangladesh is the vaccine. The Swedish ttcs are going to be important partners, an effective vaccine, which is waiting for the trawl on humans, and the tectal of the vaccine will be used for the general public before the vaccine will be conducted in Bangladesh.

If the government Considering the poison of simply research and approval, this nose will be available for use in the nose from the beginning of next year.

If the trial is successful, Bangladesh will be able to buy the vaccine at the cost of production, and even the country can produce the vaccine. It is planned to name the vaccine after the father of the nation.

The Swedish research institute Holding AB (ISR) has been very close to the trawl on humans in Bangladesh, with a few doctors and scientists of Bangladeshi origin who are living in Sweden, USA and Canada, who are involved in the preparation of this vaccine.

ISR signed a memorandum of understanding with Bangladesh Clinical Trials Limited earlier this month for Trait on Humans.

CRO's chief investigator, Dr. ABM Abdullah and Professor Dr. Ahmedul Kabir The trial of this vaccine is planned to be conducted at Mugda Medical College Hospital in the capital.

The first phase is planned to conduct this test on 180 healthy people.

When contacted, Professor Abdullah said that other two doses of coronavirus vaccines Like this vaccination, the first time should be done in front of the nose and breathe in three to four weeks after breathing.

‘The results of the Swedish vaccine on rats are very promising because its effectiveness rate is close to 100% and the vaccine has no side effects. The Prime Minister knows everything about the vaccine. We have proposed to keep it named Bangabandhu ISR.’

Professor Ahmedul Kabir said, they have already prepared the protocol and there is a possibility of submitting it to the Bangladesh Medical Research Council (BMRC) in the last week of this month for the moral approval of the trawl in Bangladesh.

Bangladesh Society of Medicine member secretary Professor Kabir said, if If the first phase of the trial is successful, the second and third phase trials will also be held in this country.

‘The biggest advantage of the trial is that Bangladesh can buy the vaccine at the cost of production. Even if the government wants to produce it under its own management,’ he said.’

According to ISR scientists, the protein for the Covid-19 virus is used to make the dry powder vaccine and it can withstand temperatures up to 40 degrees Celsius.

They also said that a major advantage in the development of the vaccine is that it is very easy to preserve compared to the current World Health Organization-affiliated COVID vaccines.

The founder of ISR, Ola Winquist, a professor of immunology at the Karolinska Institute, one of the major medical universities in Sweden, said, ‘The game-changing position of this ticker is that it can be distributed very easily without being kept in a temperature environment and it can be applied even if there is no health worker.’

ISR Chief Executive Officer Ola Winquist said in a press release on its website, ‘It is very happy to work with experts from Bangladesh for my satisfactory success in the first phase of clinical trials at the beginning of the SARS-CoV-2 virus.’

Professor Kabir said, if they get permission from clinical trials, a local drug manufacturer will provide the vaccine according to the agreement with ISR.

ISR has signed a memorandum of understanding with Unimed UniHealth Pharmaceuticals Limited on July 6 for the manufacture and distribution of COVID-19 vaccines in Bangladesh.

‘The purpose of the memorandum of understanding is to agree to a long-term cooperation with a licensing agreement that will give UniMed the exclusive right to develop and distribute ISR vaccines against the SARS-CoV-2 virus in Bangladesh,’ ISR said in a statement on its website.

It states that UNIMED will produce 100 million units of vaccines per year, with their target production of 300 million units or more in five years.

Professor Kabir said if If everything goes smoothly and BMRC gives quick approval, the first phase trial will be completed by November and the third phase trial can be started by December after analyzing the data.

Professor Kabir expressed optimism and said, ‘We hope to be in the country from January next year I can produce this vaccine.’

Starting the process

The process began when Shahjahan Saeded, a Swedish economist of Bangladesh-born Swedish economist familiar with Ola Winquist, came to know about the invention of dry powder vaccine.

Shahjahan was living in Canada of Dr. Contacted Arifur Rahman for the trawl of the vaccine in Bangladesh.

Dr. Arifur was then four American citizens of Bangladeshi origin - cardiologist Professor Dr. Chowdhury Hafiz Ahsan and Professor Dr. Masudul Hasan, Nephrologist Professor Dr. Ziauddin Ahmed Sadek and former senior UN official Mahmud Ush Sams Chowdhury were asked to contact the doctors of Bangladesh to start the trawl in Bangladesh.

Professor Abdullah and Professor Kabir then prepared a protocol for the trawl. Arifur played a major role in it and coordinated the whole matter from Sweden.

 Dr. Arifur said Bangladesh is suffering from COVID-19, so they have come forward.

‘Now everything is almost ready. I hope to get a report within 15 days on whether the vaccine has any adverse effects. We will send it to the CRO to get a report from a German company so that it can appeal to the Bangladeshi authorities for moral permission in the trawl.’

‘We hope the trial will be successful and Bangladesh will get the opportunity to lead the production of Covid vaccines,’ he said.

Professor Masudul said, ‘If everything is planned, we will consider it as a great service for the nation.’

‘Patriotism is the only driving force behind our efforts. And some of the crisis we wanted to do for the country right now. Before that, we've arranged ventilators and vaccinations from the US and sent them to Bangladesh,’ he added.

Source: The Daily Star

No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.